[Pharmacotherapy in ovarian carcinoma]

Abstract

Pharmacotherapy in Ovarian Carcinoma Although recent years have seen considerable progress in the treatment of primary and recurrent ovarian carcinoma, the mortality rate continues to be very high. Possibilities for improvement include compliance with the current treatment recommendations both in the surgical and medical areas, as well as the participation in clinical studies or treatment in study centers.